Literature DB >> 10102283

Perceived visual ability for independent mobility in persons with retinitis pigmentosa.

K A Turano1, D R Geruschat, J W Stahl, R W Massof.   

Abstract

PURPOSE: To determine the distribution of perceived ability for independent mobility in people who are at various stages of retinitis pigmentosa (RP).
METHODS: A questionnaire was developed to ask subjects to rate how difficult they found each of 35 mobility situations if they had no assistance. The scale was 1 (no difficulty) to 5 (extreme difficulty). In each of 127 subjects, the Rasch analysis, a latent trait analysis, was used to convert the ordinal difficulty ratings into interval measures of perceived visual ability for independent mobility.
RESULTS: Content validity of the questionnaire was shown by good separation indexes (4.55 and 8.0) and high reliability scores (0.96 and 0.98) for the person and the item parameters. Construct validity was shown with model fit statistics. Criterion validity of the questionnaire was shown by good discrimination among mobility-related behavior such as "limit independent travel," "always ask for accompaniment," "use a mobility aid," and "have a fear of falling." The mobility situation shown to require the least visual ability was "moving about in the home"; the situation requiring the most was "walking at night." Bivariate regression analysis determined that for every decade of disease progression, perceived visual ability for mobility decreased by approximately 0.5 logit, which was slightly less than 10% of the total range in the study sample. A linear combination of the visual function measures, log minimum angle of resolution, log contrast sensitivity, and log retinal area accounted for 57% of the variability in the person measure.
CONCLUSIONS: The patient-based assessment, developed to determine difficulty across a range of mobility situations, is a valid way to measure perceived ability for independent mobility. This latent trait varies systematically with the progression of RP and with visual function measures.

Entities:  

Mesh:

Year:  1999        PMID: 10102283

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

1.  Seeing through their eyes: lived experiences of people with retinitis pigmentosa.

Authors:  M Prem Senthil; J Khadka; K Pesudovs
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 2.  Patient-reported outcomes (PRO's) in glaucoma: a systematic review.

Authors:  S Vandenbroeck; S De Geest; T Zeyen; I Stalmans; F Dobbels
Journal:  Eye (Lond)       Date:  2011-03-18       Impact factor: 3.775

3.  Establishing Mobility Measures to Assess the Effectiveness of Night Vision Devices: Results of a Pilot Study.

Authors:  Kim T Zebehazy; George J Zimmerman; Alex R Bowers; Gang Luo; Eli Peli
Journal:  J Vis Impair Blind       Date:  2005-10

4.  Use of an augmented-vision device for visual search by patients with tunnel vision.

Authors:  Gang Luo; Eli Peli
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

5.  Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions.

Authors:  Gerald McGwin; Carrie Huisingh; Shelly G Jain; Christopher A Girkin; Cynthia Owsley
Journal:  J Glaucoma       Date:  2015-02       Impact factor: 2.503

6.  Randomized crossover clinical trial of real and sham peripheral prism glasses for hemianopia.

Authors:  Alex R Bowers; Karen Keeney; Eli Peli
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

7.  Subjective and Objective Measures of Daytime Activity and Sleep Disturbance in Retinitis Pigmentosa.

Authors:  Ava Katherine Bittner; Jennifer A Haythornthwaite; Chandni Patel; Michael T Smith
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

8.  Extended wearing trial of Trifield lens device for 'tunnel vision'.

Authors:  Russell L Woods; Robert G Giorgi; Eliot L Berson; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2010-05       Impact factor: 3.117

Review 9.  Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.

Authors:  Mary Kay Margolis; Karin Coyne; Tessa Kennedy-Martin; Timothy Baker; Oliver Schein; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa.

Authors:  Je Hyun Seo; Hyeong Gon Yu; Byung Joo Lee
Journal:  Korean J Ophthalmol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.